NCT03334422 Study of Baricitinib (LY3009104) in Patients With Moderate to Severe Atopic Dermatitis Status COMPLETED Phase PHASE3
NCT03334396 A Study of Baricitinib (LY3009104) in Patients With Moderate to Severe Atopic Dermatitis Status COMPLETED Phase PHASE3
NCT02759731 Study of Baricitinib, a JAK1/2 Inhibitor, in Chronic Graft-Versus-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation Status COMPLETED Phase PHASE1/PHASE2
NCT02758613 A Study of Baricitinib (LY3009104) in Healthy Chinese Participants Status COMPLETED Phase PHASE1
NCT02735707 Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia Status RECRUITING Phase PHASE3
NCT02708095 A Study of Baricitinib (LY3009104) in Participants With Systemic Lupus Erythematosus (SLE) Status COMPLETED Phase PHASE2
NCT02576938 A Study of Baricitinib (LY3009104) in Participants With Moderate-to-Severe Atopic Dermatitis Status COMPLETED Phase PHASE2
NCT02340104 A Study to Measure Baricitinib (LY3009104) Absorption in Healthy Participants Status COMPLETED Phase PHASE1
NCT02265705 A Study of Baricitinib (LY3009104) in Participants With Rheumatoid Arthritis (RA) Status COMPLETED Phase PHASE3
NCT01968057 A Study of Baricitinib and Ciclosporin in Healthy Participants Status COMPLETED Phase PHASE1
NCT01960140 A Study of Baricitinib and Simvastatin in Healthy Participants Status COMPLETED Phase PHASE1
NCT01937026 A Study of Baricitinib and Probenecid in Healthy Participants Status COMPLETED Phase PHASE1
NCT01925144 A Study of Baricitinib and Omeprazole in Healthy Participants Status COMPLETED Phase PHASE1
NCT01924299 A Study of Baricitinib When Administered With Ketoconazole or Fluconazole in Healthy Participants Status COMPLETED Phase PHASE1
NCT01910311 A Study of Baricitinib and Rifampicin in Healthy Participants Status COMPLETED Phase PHASE1
NCT01896726 A Study of Baricitinib and Birth Control Pills in Healthy Females Status COMPLETED Phase PHASE1
NCT01885078 An Extension Study in Participants With Moderate to Severe Rheumatoid Arthritis Status COMPLETED Phase PHASE3
NCT01870388 A Pharmacokinetic Study of Baricitinib in Participants With Liver Disease Status COMPLETED Phase PHASE1